April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA104
Academic Journal
Despite widespread use of corticosteroids and adjunctive therapies in acute severe colitis, many patients will require colectomy during admission. A recent BSG survey estimated the national colectomy rate at 28%. Several studies have identified clinical and blood variables. A proportion of patients admitted with severe colitis could have been identified early as high risk for colectomy based on admission albumin. The criteria on day 3 were not highly predictive of colectomy in this population but did have some discriminatory value. In acute severe colitis accurate prediction of colectomy remains difficult on simple criteria alone.


Related Articles

  • DISCUSSION.  // American Journal of Gastroenterology;Oct1956, Vol. 26 Issue 4, p447 

    Discusses results obtained from the surgical treatment of ulcerative colitis in the U.S. Details on the incidence of cancer in retained colons in patients not undergoing colectomy for ulcerative colitis; Percentage of patients treated medically for the disease; Accounts on the comparative...

  • COLECTOMY DURING ACUTE PHASE OF CHRONIC ULCERATIVE COLITIS. Schroeder, Morrison // American Journal of Gastroenterology;Oct1956, Vol. 26 Issue 4, p443 

    Presents several cases of patients diagnosed with ulcerative colitis in the U.S. Use of colectomy in managing the acute phase of the disease; Causes of death in acute fulminating ulcerative colitis; Risk factors of the disease.

  • Long-Term Colectomy Rate After Intensive Intravenous Corticosteroid Therapy for Ulcerative Colitis Prior to the Immunosuppressive Treatment Era. Gustavsson, Anders; Halfvarson, Jonas; Magnuson, Anders; Sandberg-Gertzén, Hanna; Tysk, Curt; Järnerot, Gunnar // American Journal of Gastroenterology;Nov2007, Vol. 102 Issue 11, p2513 

    OBJECTIVES: Corticosteroids are a cornerstone in the treatment of a severe attack of ulcerative colitis (UC). The long-term prognosis in this patient group is not well described. We studied the long-term colectomy and relapse rates in patients given intensive intravenous corticosteroid treatment...

  • Current approaches to the management of new-onset ulcerative colitis. Beery, Renée Marchioni; Kane, Sunanda // Clinical & Experimental Gastroenterology;2014, Vol. 7, p111 

    Ulcerative colitis (UC) is an idiopathic, inflammatory gastrointestinal disease of the colon. As a chronic condition, UC follows a relapsing and remitting course with medical maintenance during periods of quiescent disease and appropriate escalation of therapy during times of flare. Initial...

  • Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis. Castro, M.; Papadatou, B.; Ceriati, E.; Knafelz, D.; De Angelis, P.; Ferretti, F.; Gambarara, M.; Diamanti, A.; Peppo, F.; Rivosecchi, M. // Langenbeck's Archives of Surgery;Apr2007, Vol. 392 Issue 2, p161 

    Oral cyclosporin (CyA) has been widely and successfully used in adult patients with severe ulcerative colitis (UC) to delay or avoid colectomy. To determine if treatment with oral CyA is similarly effective in pediatric patients Data on all patients with severe UC treated with oral CyA in our...

  • Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. Roberts, Stephen E.; Williams, John G.; Yeates, David; Goldacre, Michael J. // BMJ: British Medical Journal (International Edition);11/17/2007, Vol. 335 Issue 7628, p1033 

    Objective To compare mortality outcomes in the three years after elective colectomy, no colectomy, and emergency colectomy among people admitted to hospital for inflammatory bowel disease, to inform whether the threshold for elective colectomy in clinical practice is appropriate. Design Record...

  • The "Natural History" of Inflammatory Bowel Disease and Therapeutic Decisions. Janowitz, Henry D. // American Journal of Gastroenterology;Jun1987, Vol. 82 Issue 6, p498 

    Examines the effectiveness of therapeutics in treating inflammatory bowel disease. Effect of cortisone on ulcerative colitis according to a 1955 study by Truelove and Witts; Maintenance therapy in Crohn's disease; Impact of colectomy on ulcerative colitis.

  • Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitis. Willert, Robert P.; Lawrence, Ian Craig; Koutroubakis, Ioannis E.; Brisinda, Giuseppe; Ukleja, Andrew // World Journal of Gastroenterology;4/28/2008, Vol. 14 Issue 16, p2544 

    AIM: To determine if infliximab can prevent or delay surgery in refractory ulcerative colitis (UC). METHODS: UC patients who failed to have their disease controlled with conventional therapies and were to undergo colectomy if infliximab failed to induce a clinical improvement were reviewed....

  • If at First You Don't Succeed .. Try Again? Kane, Sunanda; Johnson, David // American Journal of Gastroenterology;Jul2001, Vol. 96 Issue 7, p2260 

    The histories of patients prescribed 6-mercaptopurine over a 2-yr time were examined. Those patients who had initially failed azathioprine therapy before initiating 6-mercaptopurine were included in the study. Clinical data were collected from medical records as well as from patient interviews....


Read the Article


Sign out of this library

Other Topics